Intersect ENT to Present at Leerink Partners Global Healthcare Conference 2015
January 22, 2015 16:24 ET
|
Intersect ENT
MENLO PARK, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the Leerink Partners 2015...
Intersect ENT Announces Preliminary 2014 Financial Results
January 12, 2015 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Announces Enrollment of First Patient in Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis
December 29, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 29, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT to Present at J.P. Morgan Healthcare Conference
December 18, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Announces Changes to Board of Directors
December 10, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT to Present at Canaccord Genuity and Piper Jaffray Conferences
November 11, 2014 16:29 ET
|
Intersect ENT
MENLO PARK, Calif., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the Canaccord Genuity...
Intersect ENT Reports Third Quarter 2014 Results
November 05, 2014 16:01 ET
|
Intersect ENT
MENLO PARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT to Announce Third Quarter Financial Results
October 21, 2014 16:15 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Announces Publication of Positive Data From Three Studies of Company's Drug-Eluting Sinus Implants
October 08, 2014 17:06 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 8, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Added to Russell 2000 Index
October 01, 2014 16:37 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Intersect ENT (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...